Linwei Lu
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 10%
Papers in
- Biomaterials 19
- Nanoparticle-Based Drug Delivery 18
-
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Barrier Structure and Function Studies 2
- Co-authors
- Weiyue Lu (22 shared papers)Changyou Zhan (9 shared papers)Zhilan Chai (9 shared papers)Jingcheng Dong (16 shared papers)Cao Xie (13 shared papers)Zhengxiao Zhao (13 shared papers)Huitong Ruan (5 shared papers)Danni Ran (5 shared papers)
- Journals
- Journal of Controlled Release (10 papers)Acta Pharmaceutica Sinica B (3 papers)Molecular Pharmaceutics (2 papers)International Immunopharmacology (2 papers)Acta Biomaterialia (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Linwei Lu
39 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 101
- Biomaterials 790
- Drug Discovery 6
- Pharmaceutical Science 102
- Neurology 102
- Pharmacology 162
Countries citing papers authored by Linwei Lu
This map shows the geographic impact of Linwei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linwei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linwei Lu more than expected).
Fields of papers citing papers by Linwei Lu
This network shows the impact of papers produced by Linwei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linwei Lu. The network helps show where Linwei Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Linwei Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 328 | |
| 2 | 2017 | 221 | |
| 3 | 2016 | 102 | |
| 4 | 2023 | 66 | |
| 5 | 2016 | 60 | |
| 6 | 2015 | 55 | |
| 7 | 2018 | 55 | |
| 8 | 2019 | 55 | |
| 9 | 2020 | 49 | |
| 10 | 2021 | 48 | |
| 11 | 2019 | 47 | |
| 12 | 2022 | 46 | |
| 13 | 2019 | 45 | |
| 14 | 2019 | 45 | |
| 15 | 2019 | 42 | |
| 16 | 2022 | 38 | |
| 17 | 2020 | 34 | |
| 18 | 2022 | 32 | |
| 19 | 2019 | 31 | |
| 20 | 2024 | 31 |
About Linwei Lu
Linwei Lu is a scholar working on Biomaterials, Neurology, Complementary and alternative medicine, Pharmacology and Clinical Biochemistry, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (18 papers), Flavonoids in Medical Research (6 papers), Traditional Chinese Medicine Studies (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), RNA Interference and Gene Delivery (2 papers), Barrier Structure and Function Studies (2 papers), Medicinal Plant Pharmacodynamics Research (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Biomaterials (790 citations), Drug Discovery (6 citations), Pharmaceutical Science (102 citations), Neurology (102 citations) and Pharmacology (162 citations). Linwei Lu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Weiyue Lu, Changyou Zhan, Zhilan Chai, Jingcheng Dong, Cao Xie, Zhengxiao Zhao, Huitong Ruan, Danni Ran, Jianfen Zhou and Liangfang Zhang. Their work appears in journals such as Journal of Controlled Release, Acta Pharmaceutica Sinica B, Molecular Pharmaceutics, International Immunopharmacology and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.